BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28539620)

  • 21. Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties.
    Hassan STS; Šudomová M; Berchová-Bímová K; Šmejkal K; Echeverría J
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31405197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
    Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
    J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Phosphatidylethanolamine Biosynthesis in Herpes Simplex Virus 1-Infected Cells in Progeny Virus Morphogenesis in the Cytoplasm and in Viral Pathogenicity
    Arii J; Fukui A; Shimanaka Y; Kono N; Arai H; Maruzuru Y; Koyanagi N; Kato A; Mori Y; Kawaguchi Y
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.
    Sauter MM; Gauger JJ; Brandt CR
    Antiviral Res; 2014 Sep; 109():83-96. PubMed ID: 24995383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
    Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
    Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays.
    Zhong L; Hayward GS
    J Virol; 1997 Apr; 71(4):3146-60. PubMed ID: 9060678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral and virucidal activities against herpes simplex viruses of umesu phenolics extracted from Japanese apricot.
    Nishide M; Ikeda K; Mimura H; Yoshida M; Mitani T; Hajime Koyama A
    Microbiol Immunol; 2019 Sep; 63(9):359-366. PubMed ID: 31301156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short hairpin-loop-structured oligodeoxynucleotides reduce HSV-1 replication.
    Falkenhagen A; Heinrich J; Moelling K
    Virol J; 2009 Apr; 6():43. PubMed ID: 19397793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antiviral xanthate compound D609 inhibits herpes simplex virus type 1 replication and protein phosphorylation.
    Walro DG; Rosenthal KS
    Antiviral Res; 1997 Sep; 36(1):63-72. PubMed ID: 9330762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.
    Sanchez MD; Ochoa AC; Foster TP
    Antiviral Res; 2016 Aug; 132():13-25. PubMed ID: 27192555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G-Quadruplex Targeting in the Fight against Viruses: An Update.
    Ruggiero E; Zanin I; Terreri M; Richter SN
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. More is not always better: finding the right trade-off between affinity and selectivity of a G-quadruplex ligand.
    Zuffo M; Guédin A; Leriche ED; Doria F; Pirota V; Gabelica V; Mergny JL; Freccero M
    Nucleic Acids Res; 2018 Nov; 46(19):e115. PubMed ID: 29986058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB.
    Zheng K; Chen M; Xiang Y; Ma K; Jin F; Wang X; Wang X; Wang S; Wang Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):990-6. PubMed ID: 24657267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the Super Elongation Complex Suppresses Herpes Simplex Virus Immediate Early Gene Expression, Lytic Infection, and Reactivation from Latency.
    Alfonso-Dunn R; Arbuckle JH; Vogel JL; Kristie TM
    mBio; 2020 Jun; 11(3):. PubMed ID: 32518191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-quadruplexes may determine the landscape of recombination in HSV-1.
    Saranathan N; Biswas B; Patra A; Vivekanandan P
    BMC Genomics; 2019 May; 20(1):382. PubMed ID: 31096907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCCTC-Binding Factor Acts as a Heterochromatin Barrier on Herpes Simplex Viral Latent Chromatin and Contributes to Poised Latent Infection.
    Lee JS; Raja P; Pan D; Pesola JM; Coen DM; Knipe DM
    mBio; 2018 Feb; 9(1):. PubMed ID: 29437926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, Binding and Antiviral Properties of Potent Core-Extended Naphthalene Diimides Targeting the HIV-1 Long Terminal Repeat Promoter G-Quadruplexes.
    Perrone R; Doria F; Butovskaya E; Frasson I; Botti S; Scalabrin M; Lago S; Grande V; Nadai M; Freccero M; Richter SN
    J Med Chem; 2015 Dec; 58(24):9639-52. PubMed ID: 26599611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of herpes simplex virus type 1 replication in Vero cells by Psychotria serpens: relationship to gene expression, DNA replication, and protein synthesis.
    Kuo YC; Chen CC; Tsai WJ; Ho YH
    Antiviral Res; 2001 Aug; 51(2):95-109. PubMed ID: 11431035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UBE1a Suppresses Herpes Simplex Virus-1 Replication.
    Ikeda M; Ito A; Sekine Y; Fujimuro M
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33291814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-Carboline derivatives as novel antivirals for herpes simplex virus.
    Gonzalez MM; Cabrerizo FM; Baiker A; Erra-Balsells R; Osterman A; Nitschko H; Vizoso-Pinto MG
    Int J Antimicrob Agents; 2018 Oct; 52(4):459-468. PubMed ID: 30006037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.